Important Class Action Reminders for CTXS, GAIA, and DAKT Investors: Don’t Miss Out on Your Opportunity to Participate!

Class Action Lawsuit Reminder New York, Jan. 06, 2023 (GLOBE NEWSWIRE) Attorney Advertising–Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Law…

Read More

Maximize Your Investment Potential: Submit Your Losses to Johnson Fistel for Fate Therapeutics Shareholder Investigation

Fate Therapeutics Shareholder Investigation: Submit Your Losses to Johnson Fistel FATE Class Action Investigation has Been Commenced on Behalf of Shareholders SAN DIEGO, Jan. 06, 2023 (GLOBE NEWSWIRE) — Shareholder rights law firm Johnson Fistel, LLP is investigating whether Fate Therapeutics, Inc. (NASDAQ: FATE) (“Fate” or the “Company), any of its executive officers, or others…

Read More

Deception Technology Solutions on the Rise: Spike in APTs and Zero-Day Attacks to Drive Demand – According to Fact.MR Report

Global Deception Technology Market Expanding Significantly Spike in APTs and Zero-Day Attacks Driving Demand Rising Need for Effective Solutions for Early Identification of Attackers Rockville, Jan. 06, 2023 (GLOBE NEWSWIRE) — Fact.MR, a market research and competitive intelligence provider, reveals that the global deception technology market is experiencing significant growth. This growth is being driven…

Read More

OrthoPediatrics Corp Expands into Germany with New Direct Sales Organization: A Game-Changing Move in the World of Orthopedic Medicine

OrthoPediatrics Corp. Establishes Direct Sales Organization in Germany WARSAW, Ind., Jan. 06, 2023 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the establishment of its direct sales organization in Germany. Expanding Commitment OrthoPediatrics GmbH commenced operations on January 1,…

Read More

Unlocking the Potential: Hypophosphatasia Treatment Market Projected to Reach $26.27 Million by 2033, with a 5% CAGR – Insights from Future Market Inc.

Hypophosphatasia Treatment Market: A Growing Industry Asia Pacific to Lead the Way The Asia Pacific hypophosphatasia treatment market is projected to experience the highest CAGR of 4.8% during the forecast period of 2023 to 2033. Within this region, the Odontohypophosphatasia segment is expected to see a CAGR of 4.9% over the analysis period. This rapid…

Read More

Important Update: Broad Capital Acquisition Corp. Special Meeting of Shareholders Postponed to January 10, 2023

Broad Capital Acquisition Corp Announces Postponement of Special Meeting of Shareholders Until January 10, 2023 Plano, Texas, Jan. 05, 2023 (GLOBE NEWSWIRE) Broad Capital Acquisition Corp (the “Company”) (Nasdaq: BRAC/BRACU/BRACR), a special purpose acquisition company, today announced that it has postponed the Special Meeting of Shareholders scheduled to occur on January 9, 2023 (the “Special…

Read More

Uh-Oh, Fate Alert: Monsey Law Firm on the Case of Wohl & Fruchter LLP Investigating Possible Securities Claims Against Fate Therapeutics Inc.

Welcome to the Wild World of Securities Investigations What Happened in Monsey? It was a typical day in Monsey, N.Y., when the news broke – the law firm of Wohl & Fruchter LLP is investigating whether Fate Therapeutics, Inc. (Nasdaq: FATE) violated federal securities laws. Specifically, they’re looking into the sudden termination of Fate’s collaboration…

Read More